Interleukin-6 and interleukin-10 gene polymorphism, endothelial dysfunction, and postoperative prognosis in patients with peripheral arterial disease

Journal of Vascular Surgery

Volumn 52, Issue 1, 2010, Pages 103-109

  Stoica, Adina Liliana ^a   Stoica, Emanuel ^a   Constantinescu, Ileana ^b   Uscatescu, Valentina ^b   Ginghina, Carmen ^a  

^a Institutul de Boli Cardiovasculare Prof Dr CC Iliescu   (Romania)

^b FUNDENI CLINICAL INSTITUTE   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6;

ACUTE HEART INFARCTION; ADULT; ARTERY DISEASE; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ECHOGRAPHY; ELECTIVE SURGERY; ENDOTHELIAL DYSFUNCTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEART ARREST; HEART DEATH; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; STROKE; ULTRASOUND; UNSTABLE ANGINA PECTORIS; VASCULAR SURGERY; VASODILATATION;

ACUTE DISEASE; AGED; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; ENDOTHELIUM, VASCULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES; VASODILATION;

EID: 77953686076     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.01.088     Document Type: Article

References (32)

1. Biasucci L.M., Vitelli A., Liuzzo G., Altamura S., Caligiuri G., Monaco C., et al. Elevated levels of interleukin-6 in unstable angina. Circulation 94 (1996) 874-877
2. Sturk A., Hack C.E., Aarden L.A., Mieke B., Koster R.R.W., and Sanders G.T.B. Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med 119 (1992) 574-579
3. Neumann F.J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92 (1995) 748-5
4. Tzoulaki I., Murray G., Lee A.J., Rumley A., Lowe G.D.O., and Fowkes G.R. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral artheriosclerosis in the general population: Edinburgh Artery Study. Circulation 112 (2005) 976-983
5. Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., et al. Interleukin-6 gene - 174 G>C and - 572 G>C promoter polymorphism are strong predictors of plasma interleukin-6 levels after coronary artery by-pass surgery. Arterioscler Thromb Vasc Biol 21 (2001) 1458-1463
6. Amirzargar A., Sadeghi N.M., Khosravi F., Dianat S., Naroueynejad M., Nicknam M.H., et al. Th1 and Th2 cytokine gene polymorphisms in two indigenous ethnic groups in Iran. Int J Immunogenetics 33 (2006) 429-437
7. Humphries S., Luong L., Ogg M.S., Hawe E., and Miller G.J. The interelukin-6, 174G.C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22 (2001) 243-252
8. Jones K.G., Brull D.J., Brown L.C., Sian M., Greenhalgh R.M., Humphries S.E., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265
9. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin-6 transcriptional regulation. J Biol Chem 275 (2000) 18138-18144
10. Sankaran D., Asderakis A., Ashraf S., Roberts I.S., Short C.D., Dyer P.A., et al. Citokine gene polymorphism predict acute graft rejection following renal transplantation. Kidney Int 56 (1999) 281-288
11. Amirzargar A., Rezaei N., Jabbari H., DAnesh A., Khosravi F., Hajabdolbaghi M., et al. Citokine single nucleotide polymorphism in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 17 (2006) 84-89
12. Suwaidi Z.A., Hamasaki S., Higano S.T., Nishinura T.A., Holmes D.R., and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
13. Schachiniger W., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilatator dysfunction on adverse long term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
14. Anderson T.J., Uehata A., Gerhard M.D., Meredith I.T., Knab S., Delagrange D., et al. Close relation of endothelial function in the women coronary and peripheral circulation. J Am Coll Cardiol 26 (1995) 1235-1241
15. Eagle K.A., Berger P.B., Calkins H., Chaitman B.R., Ewy G.A., Fleischmann K.E., et al. ACC/AHA guideline update on perioperative cardiovascular evaluation for noncardiac surgery. Circulation 105 (2002) 1257-1267
16. 01. Celermajer D.S., Sorensen K.E., Gooch V.M., Miller, Sullivan I.D., Lloyd J.K., et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340 (1992) 1111-1115
17. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., and Deanfield J.E. Endothelium-dependent dilatation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24 (1994) 1468-1474
18. Correti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilatation of the brachial artery. A Report of the International Brachial Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
19. Jerrard-Dunne P., Sitzer M., Risley P., Steckel D.A., Buehler A., von Kegler S., et al. Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis. Stroke 34 (2003) 402-407
20. Flex A., Gaetani E., Papaleo P., Straface G., Proia A.S., Pecorini G., et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke 35 (2004) 2270-2275
21. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
22. Lu Q., van Dam R.M., Meigs J.B., Manson J.E., Hunter D., and Hu F.B. Genetic variation in IL-6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case. Control study and meta-analysis. Human Molec Genetics 11 (2006) 1914-1920
23. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 85 (1999) e17-e24
24. Pinderski Oslund L.J., Hedrick C.C., Olvera T., Hagenbaugh A., Territo M., Berliner J.A., et al. Interleukin-10 blocks atherosclerotic events in vitro and in vivo. Arterioscler Thromb Vasc Biol 19 (1999) 2847-2853
25. Heeschen C., Dimmeler S., Hamm C.W., Fishtlscherer S., Boersma E., Simoons M.L., et al. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107 (2003) 2109-2114
26. Kahraman S., Ylmaz R., Arici M., Altun B., Erdem Y., Yasavul U., et al. IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J Nephrol 19 (2006) 50-56
27. George S., Ruan X.Z., Navarrete C., Turner D., Reynard M., Sweny P., et al. Renovascular disease is associated with low producer genotype of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 63 (2004) 470-475
28. Fichtlscherer S., Breuer S., Heeschen C., Dimmeler S., and Zeiher A.M. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol 44 (2004) 44-49
29. Gokce N., Keaney Jr. J.F., Hunter L.M., Watkins M.T., Menzoian J.O., and Vita J.A. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105 (2002) 1567-1572
30. Gokce N., Keaney Jr. J.F., Hunter L.M., Watkins T.M., Nedeljkovic Z.S., Menzoian J.A., et al. Predictive value noninvasively determined endothelial dsyfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41 (2003) 1769-1775
31. Brevetti G., Silvestro A., Di Giacomo S., Bucur R., Di Donato A.M., Schiano V., et al. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 38 (2003) 374-379
32. Brevetti G., Silvestro A., Schiano V., and Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease. Circulation 108 (2003) 2093-2098